Link-Asia International Medtech Group Ltd. (1143) AI Stock Analysis

• Market Cap: HK$82.99M
• Dividend Yield: N/A
• Average Volume (3M): 918.53K
• Price to Earnings (P/E): 11.0
• Beta (1Y): 0.57
• Revenue Growth: -4.52%
• EPS Growth: 55.30%
• Country: HK
• Employees: 835
• Sector: Technology
• Sector Strength: 78
• Industry: Consumer Electronics
• EPS (TTM): 0.05
• Shares Outstanding: 224,289,180
• 10 Day Avg. Volume: 2,060,160
• 30 Day Avg. Volume: 918,526
• PEG Ratio: 0.03
• Price to Book (P/B): 0.17
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.60
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 47 Neutral
• Price Target: ―

Link-Asia International Medtech Group Ltd. has a challenging financial outlook with mixed performance in profitability and cash flow management. The stock's technical indicators point to a bearish trend, with momentum indicators showing oversold conditions. While the valuation appears attractive based on the P/E ratio, the lack of a dividend yield may deter certain investors. Overall, the stock currently scores low due to financial instability and technical weakness.

Link-Asia International Medtech Group Ltd. Business Overview & Revenue Model

Company Description

Link-Asia International MedTech Group Limited, an investment holding company, provides electronic manufacturing services (EMS) for the telecommunications, security, car electronics, home appliances, other consumer, and industrial electronic products. The company operates through four segments: EMS, Distribution of Communications Products, Securities and Other Assets Investment, and Real Estate Supply Chain Services. It is also involved in the trade of personal care products, business telephone systems, and telecommunication products; manufacture and sale of telecommunications and other products, and consumable electronic products; sale of audio equipment; and provision of consultancy services, as well as pre-pregnancy care and assisted reproductive services. In addition, the company offers equity investment and property agency services; and real estate advisory and purchase services. It operates in the People's Republic of China, the United States, Switzerland, France, Poland, the United Kingdom, Belgium, Russia, Thailand, Malaysia, Brazil, and internationally. The company was formerly known as Link-Asia International Co. Ltd. and changed its name to Link-Asia International MedTech Group Limited in December 2020. Link-Asia International MedTech Group Limited was founded in 1992 and is headquartered in Tsim Sha Tsui, Hong Kong.

How the Company Makes Money

Link-Asia International MedTech Group Ltd. generates revenue primarily through the sale of its medical devices and healthcare solutions. The company likely engages in partnerships with healthcare providers, hospitals, and clinics to distribute its products. Revenue streams may include direct sales, long-term supply agreements, and possibly service contracts for maintenance and support of their medical technology. The company's earnings are influenced by factors such as product innovation, market demand, regulatory approvals, and its ability to establish and maintain strong relationships with key stakeholders in the healthcare industry.

Link-Asia International Medtech Group Ltd. Financial Statement Overview

Summary

Link-Asia International Medtech Group Ltd. presents a mixed financial profile with stable equity but faces challenges in consistent revenue and cash flow. The income statement shows declining revenues and volatile net profit margins, though EBIT margins have recently improved. The balance sheet is stable with a moderate debt-to-equity ratio, but fluctuating liabilities are a concern. Cash flow management is inconsistent, with periods of negative operating cash flow impacting liquidity.

Income Statement

Link-Asia International Medtech Group Ltd. has shown mixed results over recent years. The company experienced declining revenues with a negative growth trend from 2019 to 2024, particularly from 2021 to 2024. While gross profit margins remained relatively stable, net profit margins were volatile, indicating potential profitability issues. The positive EBIT margin in 2024 is a welcome improvement, although historical EBIT margins were negative.

Balance Sheet

The company's balance sheet reveals a stable equity position with a moderate debt-to-equity ratio, indicating a balanced capital structure. The equity ratio has improved over time, suggesting a strengthening financial foundation. However, the fluctuating total debt and liabilities pose potential risks to financial stability.

Cash Flow

Cash flow analysis indicates inconsistent cash flow management. Operating cash flow was negative in several years, impacting free cash flow generation. Though there was a significant improvement in free cash flow in 2022, the lack of consistent positive cash flow raises concerns about long-term liquidity.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
479.32M	502.00M	529.25M	675.52M	595.02M
	Gross Profit
123.60M	136.87M	101.40M	144.89M	154.71M
	EBIT
15.18M	11.39M	-57.07M	-65.91M	-137.08M
	EBITDA
4.78M	40.49M	-14.06M	-4.54M	-116.52M
	Net Income Common Stockholders
8.04M	5.26M	-54.04M	-46.40M	-173.05M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
312.05M	271.57M	252.21M	146.80M	167.66M
	Total Assets
880.14M	776.42M	659.23M	677.98M	657.40M
	Total Debt
86.60M	26.75M	51.08M	61.20M	70.19M
	Net Debt
-225.45M	-244.82M	-201.13M	-84.37M	-97.46M
	Total Liabilities
343.25M	287.69M	297.22M	311.98M	361.47M
	Stockholders Equity
536.53M	486.66M	359.86M	365.88M	295.46M
Cash Flow		Free Cash Flow
0.00	-132.09M	99.60M	-122.55M	-45.85M
	Operating Cash Flow
0.00	-129.29M	107.55M	-100.45M	-15.04M
	Investing Cash Flow
0.00	39.98M	-547.00K	3.31M	-96.19M
	Financing Cash Flow
0.00	101.84M	2.20M	74.19M	35.17M

Link-Asia International Medtech Group Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.37
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1143, the sentiment is Positive. The current price of 0.37 is above the 20-day moving average (MA) of 0.32, above the 50-day MA of 0.30, and below the 200-day MA of 0.70, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 68.06 is Neutral, neither overbought nor oversold. The STOCH value of 47.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1143.

Link-Asia International Medtech Group Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$11.80B	10.08	-7.46%	2.99%	7.37%	-8.21%
8083	55 Neutral	$3.18B	―	-16.87%	―	-2.35%	-837.50%
8143	51 Neutral	HK$149.93M	―	-18.22%	―	-56.16%	62.50%
1143	47 Neutral	HK$82.99M	10.98	1.60%	―	-4.52%	55.30%
8186	44 Neutral	HK$25.96M	134.12	0.88%	―	8.34%	―
8081	41 Neutral	HK$226.87M	―	-30.23%	―	5.79%	-780.00%
8196	40 Underperform	HK$27.69M	―	-9.50%	―	-58.07%	-331.12%

Link-Asia International Medtech Group Ltd. Corporate Events

China Energy Storage Technology Development Ltd. Announces 2025 AGM

China Energy Storage Technology Development Limited, previously known as Link-Asia International MedTech Group Ltd., has announced its annual general meeting scheduled for June 20, 2025, in Hong Kong. The meeting will address several resolutions including the adoption of the company’s audited accounts for 2024, reappointment of auditors, re-election of executive directors, and authorizing the board to issue additional shares. These resolutions are aimed at strengthening the company’s governance and operational capabilities.

Link-Asia International Medtech Group Delays Circular Dispatch, Revises Timetable

Link-Asia International Medtech Group Ltd., now known as China Energy Storage Technology Development Limited, is involved in a proposed rights issue, change in board lot size, and a major transaction related to the assignment of distribution rights. The company announced a delay in the dispatch of a circular containing details of these proposals, which impacts the expected timetable for these initiatives. The circular is now expected to be dispatched by May 8, 2025, affecting the timeline for shareholder meetings and related activities.

China Energy Storage Technology Reports 2024 Annual Results

China Energy Storage Technology Development Limited announced its annual results for the year ended December 31, 2024, reporting a slight decrease in revenue from continuing operations to HK$479,317,000 compared to the previous year. Despite the revenue drop, the company achieved a higher profit from continuing operations, amounting to HK$6,457,000, up from HK$4,881,000 in 2023, indicating improved operational efficiency and cost management.

China Energy Storage Technology Development Ltd. Reschedules Board Meeting

China Energy Storage Technology Development Limited, formerly known as Link-Asia International Medtech Group Ltd., announced a change in the date of its board meeting. Originally scheduled for March 28, 2025, the meeting has been moved to March 31, 2025, to allow more time to finalize the annual results for the year ending December 31, 2024. This delay may impact the timing of the approval of the annual results and any decision regarding the final dividend payment.

China Energy Storage Technology Announces Delay in Rights Issue Circular

China Energy Storage Technology Development Limited, formerly known as Link-Asia International MedTech Group Ltd., is involved in a rights issue, a change in board lot size, and a major transaction related to the assignment of distribution rights. The company announced a further delay in the dispatch of a circular detailing these activities, now expected by April 17, 2025, impacting the timeline for shareholder meetings and related transactions.

China Energy Storage Technology Schedules Board Meeting for Annual Results

China Energy Storage Technology Development Limited has announced a board meeting scheduled for March 28, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend and address other business matters, potentially impacting the company’s financial strategy and stakeholder interests.

China Energy Storage Technology Development Announces Delay in Circular Dispatch

Link-Asia International Medtech Group Ltd., now known as China Energy Storage Technology Development Limited, is involved in a major transaction concerning the assignment of distribution rights and a proposed rights issue. The company has announced a further delay in the dispatch of a circular detailing these transactions, which include a change in board lot size and a major rights issue. This delay impacts the expected timetable for these corporate actions, pushing the dispatch date to March 26, 2025, and affecting subsequent shareholder meetings and voting schedules.